arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

RadNet, Inc.

RDNT
$73.17 ▼ -0.81 (-1.09%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Neutral
auto_awesome

Analytical Summary

RadNet, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $5.7B
Dividend Yield
Revenue Growth 25.0%
Op. Margin 6.3%
ROIC 1.2%
FCF / Share $1.21
Trailing P/E 731.7x
Price / Book 5.3x
FCF Yield 1.7%
Debt / Equity 1.22
info Valuation on last close. End-of-day price, Sep 23, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$622.72M
↑ +25.0%
Net Income Profit after all expenses
$7.53M
↓ -47.9%
Operating Margin Operating profit as % of sales
6.3%
↑ +252.6% 37th
FCF / Share Free cash flow per share
$1.21
↑ +18.0%
Long-Term Debt Long-term obligations
$1.33B
↑ +22.6%

Health Breakdown

Profitability
46
Returns
42
Financial Health
41
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 67 quarters